Infraclavicular Brachial Plexus Block With Bupivacaine Alone or With Both Dexmedetomidine and Dexamethasone

Launched by SUEZ CANAL UNIVERSITY · Apr 9, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a type of pain management technique called an infraclavicular brachial plexus block, which helps numb the arm and shoulder area during surgeries on the forearm and hand. Researchers are comparing the effects of a local anesthetic called bupivacaine alone to bupivacaine combined with two other medications, dexmedetomidine and dexamethasone. The goal is to find out if these additional medications can make the pain relief last longer and improve the overall experience for patients undergoing surgery.

To participate in this trial, individuals need to be between 18 and 65 years old and in generally good health. They should have a body mass index (BMI) between 18 and 35 and be scheduled for specific surgeries on their forearm or hand. However, people with certain conditions, such as bleeding disorders, infections, or allergies to the study medications, will not be eligible. If someone joins the trial, they can expect to receive either the standard treatment or the enhanced treatment to see which works better for pain relief after their surgery. This study might be important for finding better ways to manage pain and reduce the need for stronger pain medications after surgery.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age 18-65 years
• • American Society of Anesthesiologists physical status I-II
• • Body mass index between 18 and 35 kg/ m2
• • scheduled for forearm and hand surgeries
• Exclusion Criteria:
• • Inability to consent to the study
• • Coagulopathy
• • Sepsis
• • Decompensated chronic hepatic or renal illnesses
• • Allergy to any of the used drugs
• • Pre-existing musculocutaneous/median/radial/ ulnar neuropathy
• • Prior surgery in the infraclavicular fossa